Institutional investors purchased a net $629.5 thousand shares of NEO during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 55.32% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FALCON POINT CAPITAL LLC Bought 45.8 Thousand shares of Neogenomics Inc
GRANAHAN INVESTMENT MANAGEMENT, ... Sold 43.8 Thousand shares of Neogenomics Inc
CORTINA ASSET MANAGEMENT LLC Sold 84.5 Thousand shares of Neogenomics Inc